BioMarin to Host Third Quarter 2013 Financial Results

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
BioMarin to Host Third Quarter 2013 Financial Results Conference Call and Webcast on Thursday, October 24 at 5:00 p.m. ET

SAN RAFAEL, Calif., Oct. 10, 2013 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) today announced that Jean-Jacques Bienaimé, Chief Executive Officer of BioMarin, will host a conference call and webcast on Thursday, October 24, at 5:00 p.m. ET to discuss third quarter 2013 financial results.

U.S. / Canada Dial-in Number: 877.303.6313
International Dial-in Number: 631.813.4734
Conference ID: 32118292

Replay Dial-in Number: 855.859.2056
Replay International Dial-in Number: 404.537.3406
Conference ID: 32118292

Interested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website, www.BMRN.com . A replay of the call will be archived on the site for one week following the call.

About BioMarin

BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio comprises four approved products and multiple clinical and pre-clinical product candidates. Approved products include Naglazyme® (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme® (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; Kuvan® (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany; and Firdapse® (amifampridine), which has been approved by the European Commission for the treatment of Lambert Eaton Myasthenic Syndrome (LEMS). Product candidates include Vimizim (N-acetylgalactosamine 6-sulfatase), formally referred to as GALNS, which successfully completed Phase III clinical development for the treatment of MPS IVA, PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase), which is currently in Phase III clinical development for the treatment of PKU, BMN-701, a novel fusion protein of insulin-like growth factor 2 and acid alpha glucosidase (IGF2-GAA), which is currently in Phase I/II clinical development for the treatment of Pompe disease, BMN 673, a poly ADP-ribose polymerase (PARP) inhibitor, which is currently in Phase I/II clinical development for the treatment of genetically-defined cancers, and BMN-111, a modified C-natriuretic peptide, which is currently in Phase I clinical development for the treatment of achondroplasia. For additional information, please visit www.BMRN.com . Information on BioMarin's website is not incorporated by reference into this press release.

Vimizim™ is our trademark, and BioMarin ® , Naglazyme ® , Kuvan ® , Firdapse ® are registered trademarks of BioMarin Pharmaceutical Inc.

Aldurazyme ® is a registered trademark of BioMarin/Genzyme LLC.

Investors Traci McCarty BioMarin Pharmaceutical Inc. (415) 455-7558 Media Debra Charlesworth BioMarin Pharmaceutical Inc. (415) 455-7451

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Omneky Outshines Competitors in AI Ad Scoring

Updated Category News Views 10

Brewing a better ad with AI isn't just about the model you plug in—it's about the wizardry wrapping around it. Omneky's latest caper in the AI advertising game has snagged the spotlight, pulling a hearty 8.8 taste score on a recent TasteBench comparison. That's not a minor tweak, folks, but a whopping 1.2-point lead over the shadow-chasing curves of the next...

Continue Reading
Veterans Transitioning to Real Estate with Scholarships

Updated Category News Views 9

Tapping Military Skills for Civilian Gain Finding a new career after military service is a mountain of a task, but veterans now have a golden ticket into the real estate appraisal world. The Appraisal Institute's Next Mission Scholarship is throwing veterans a $1,000 life preserver to dive into a field where their military-honed skills already shine. The Power of a...

Continue Reading
AtWork Welcomes Franchise Vet Sarah Goehring

Updated Category News Views 8

A Strategic Move for AtWork There's a new heavyweight at AtWork, a name that's been catching attention in the franchise biz lately—Sarah Goehring. This isn't just another appointment; it's a signal flare for AtWork's ambitions. With Goehring, they're doubling down on scaling their operation and drawing in more franchise players who are ready to hit the ground running....

Continue Reading
Coventry's Jacobs Joins European Life Settlement Execs

Updated Category News Views 12

Neal Jacobs Steps Up in Life Settlements Coventry has added another feather to its cap with Neal Jacobs, their Senior Managing Director of Capital Markets, joining the Executive Committee of the European Life Settlement Association (ELSA). Elected at ELSA's Annual General Meeting on September 15, 2026, Jacobs brings a wealth of experience that promises to bolster the...

Continue Reading
Think Tank Pushes for Bold Parkinson's Prevention Plan

Updated Category News Views 13

A New Era for Parkinson's Disease Prevention The Parkinson's Foundation has rolled out its battle plan to take on Parkinson's disease from the ground up, shifting gears from managing symptoms to stopping the illness before it starts. It's about damn time, too. With the disease being the fastest-growing neurodegenerative disorder and impacting 10 million people worldwide,...

Continue Reading
VetsinTech's AI Training Boosts Military Careers

Updated Category News Views 17

A New Spin on Engineering Careers Sometimes it feels like every corner I turn in this market maze, there’s something about AI. It’s not just chirping in the tech world anymore; it’s banging on the doors of sectors like engineering, aerospace, and manufacturing. And now, VetsinTech is tossing its hat into the AI ring with a fresh program aimed at blending military...

Continue Reading
Special Needs Group Partners with MAST to Enhance Accessibility

Updated Category News Views 8

Accessible Travel Takes the Spotlight Ah, the travel biz—just when you think you’ve got it all figured out, along comes a partnership like this to shake things up. Special Needs Group, the big cheese in mobility and medical equipment rentals, is teaming up with MAST Travel Network. Together, they're rolling out initiatives to make the world a bit more accessible, even...

Continue Reading
OmniActive's Fenavari: A New Era in Women's Health

Updated Category News Views 12

Pioneering Women's Health with Fenavari You ever wonder why some health products get all the hype? Here's one for the book: OmniActive Health Technologies launching Fenavari, their top-tier contender in the women's health market. Now, we're not talking your run-of-the-mill supplement here. We're stepping onto a new playing field, especially with Dr. Taz Bhatia stepping...

Continue Reading
New American Funding Expands in Carolinas with Mullinix Move

Updated Category News Views 9

The Gathering of Mortgage Titans You don't just waltz into the mortgage world with a $2 billion track record and expect folks not to notice. Will Mullinix, a name that's become synonymous in the Carolinas with mortgage mastery, has decided to bring his influential Mullinix Mortgage Group under the banner of New American Funding. Talk about a power play. This bold strategy...

Continue Reading
Quark Baby's Milk Warmer Debut at Vancouver & Dubai

Updated Category News Views 6

An Unconventional Pitch for Baby Gear Quark Baby is strutting its stuff not just in Vancouver but all the way in Dubai. Yeah, we're talking about a milk warmer hitting two major expos. What's the deal with an award-winning brand from Vancouver making so much noise? From October 17-18, they're home-court at The Baby Show Vancouver, and by October 22-24, they're in Dubai at...

Continue Reading

Top 5 Most Recently Viewed Articles

AstraZeneca PLC (AZN) Investors Invited to Join Lawsuit Claims

Updated Category News Views 186

AstraZeneca PLC Investors: Important Legal Updates Attention all investors who have felt the sting of financial loss in AstraZeneca PLC (NASDAQ: AZN). You are not alone, and there's an opportunity for you to participate in a securities fraud lawsuit that could address these losses. The Law Offices of Howard G. Smith are reminding those affected of the impending deadline...

Continue Reading
WOW! Expands Fiber Internet Footprint in Spring Hill Area

Updated Category News Views 205

WOW! Unveils Fiber Internet Services in Spring Hill WOW! Internet, TV & Phone (NYSE: WOW), a prominent provider of broadband services, is excited to announce its all-fiber network is now available in Spring Hill. This marks a significant milestone, as Spring Hill becomes the 10th Greenfield community in the region to gain access to WOW!'s advanced fiber internet services....

Continue Reading
Cycurion Secures State Management Contract to Enhance Services

Updated Category News Views 139

Cycurion Awarded State Management Consulting Services Contract Cycurion, Inc. is thrilled to announce that it has secured a prominent position in the State of Florida’s Management Consulting Services Term Contract. This achievement, highlighted in RFP No. 25-80101500-RFP-V2, issued by the Florida Department of Management Services, allows Cycurion to serve as an approved...

Continue Reading
AGCO Welcomes Zhanna Golodryga to Board of Directors

Updated Category News Views 329

AGCO Announces New Board Member: Zhanna Golodryga AGCO Corporation (NYSE: AGCO), a leader in agricultural machinery and precision agriculture, has made a significant addition to its Board of Directors with the election of Zhanna Golodryga. Effective immediately, this decision aligns with AGCO’s strategic goals, particularly in areas of technology enhancement and...

Continue Reading
ServiceNow's Potential $3 Billion Acquisition of Moveworks AI

Updated Category News Views 318

ServiceNow Strategizes for a Major AI Acquisition ServiceNow Inc (NASDAQ: NOW) is on the brink of an exciting deal to acquire the AI-focused firm Moveworks. This acquisition, valued at approximately $3 billion according to recent reports, aims to bolster ServiceNow's capabilities in automating enterprise workflows and enhancing customer interactions through advanced...

Continue Reading